The Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian Study

BACKGROUND: Egypt has one of the highest (16-8%) prevalence rates of HCV infection in the world. Approximately 90% of Egyptian HCV isolates belong to a single subtype (4a), which responds less successfully to interferon therapy than other subtypes. Studies comparing the efficacy and safety of PEGIFN...

Descripción completa

Detalles Bibliográficos
Autores principales: El Raziky, Maissa, Fathalah, Waleed Fouad, El-akel, Wafaa Ahmed, Salama, Ahmed, Esmat, Gamal, Mabrouk, Mahassen, Salama, Rabab Mamoun, Khatab, Hany Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732660/
https://www.ncbi.nlm.nih.gov/pubmed/23922556
http://dx.doi.org/10.5812/hepatmon.10069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732660/
https://www.ncbi.nlm.nih.gov/pubmed/23922556
http://dx.doi.org/10.5812/hepatmon.10069

Ejemplares similares